Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
73
REVS Quote, Financials, Valuation and Earnings
Last price:
$28.99
Seasonality move
:
-2.4%
Day range:
$28.92 - $29.21
52-week range:
$21.79 - $29.39
Dividend yield:
1.04%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
35.6K
Avg. volume:
97.3K
1-year change:
13.87%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
REVS
Columbia Research Enhanced Value ETF
|
-- | -- | -- | -- | -- |
|
FNDX
Schwab Fundamental US Large Company ETF
|
-- | -- | -- | -- | -- |
|
FVAL
Fidelity Value Factor ETF
|
-- | -- | -- | -- | -- |
|
QDEF
FlexShares Quality Dividend Defensive Index Fund
|
-- | -- | -- | -- | -- |
|
ULVM
VictoryShares US Value Momentum ETF
|
-- | -- | -- | -- | -- |
|
VALQ
American Century US Quality Value ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
REVS
Columbia Research Enhanced Value ETF
|
$29.01 | -- | -- | -- | $0.60 | 1.04% | -- |
|
FNDX
Schwab Fundamental US Large Company ETF
|
$28.18 | -- | -- | -- | $0.12 | 1.58% | -- |
|
FVAL
Fidelity Value Factor ETF
|
$73.16 | -- | -- | -- | $0.38 | 1.59% | -- |
|
QDEF
FlexShares Quality Dividend Defensive Index Fund
|
$82.26 | -- | -- | -- | $0.54 | 1.71% | -- |
|
ULVM
VictoryShares US Value Momentum ETF
|
$95.31 | -- | -- | -- | $0.02 | 1.7% | -- |
|
VALQ
American Century US Quality Value ETF
|
$68.31 | -- | -- | -- | $0.32 | 1.82% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
REVS
Columbia Research Enhanced Value ETF
|
-- | 0.601 | -- | -- |
|
FNDX
Schwab Fundamental US Large Company ETF
|
-- | 0.707 | -- | -- |
|
FVAL
Fidelity Value Factor ETF
|
-- | 0.887 | -- | -- |
|
QDEF
FlexShares Quality Dividend Defensive Index Fund
|
-- | 0.626 | -- | -- |
|
ULVM
VictoryShares US Value Momentum ETF
|
-- | 0.792 | -- | -- |
|
VALQ
American Century US Quality Value ETF
|
-- | 0.542 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
REVS
Columbia Research Enhanced Value ETF
|
-- | -- | -- | -- | -- | -- |
|
FNDX
Schwab Fundamental US Large Company ETF
|
-- | -- | -- | -- | -- | -- |
|
FVAL
Fidelity Value Factor ETF
|
-- | -- | -- | -- | -- | -- |
|
QDEF
FlexShares Quality Dividend Defensive Index Fund
|
-- | -- | -- | -- | -- | -- |
|
ULVM
VictoryShares US Value Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
VALQ
American Century US Quality Value ETF
|
-- | -- | -- | -- | -- | -- |
Columbia Research Enhanced Value ETF vs. Competitors
-
Which has Higher Returns REVS or FNDX?
Schwab Fundamental US Large Company ETF has a net margin of -- compared to Columbia Research Enhanced Value ETF's net margin of --. Columbia Research Enhanced Value ETF's return on equity of -- beat Schwab Fundamental US Large Company ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital REVSColumbia Research Enhanced Value ETF-- -- -- FNDXSchwab Fundamental US Large Company ETF-- -- -- -
What do Analysts Say About REVS or FNDX?
Columbia Research Enhanced Value ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Schwab Fundamental US Large Company ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Columbia Research Enhanced Value ETF has higher upside potential than Schwab Fundamental US Large Company ETF, analysts believe Columbia Research Enhanced Value ETF is more attractive than Schwab Fundamental US Large Company ETF.
Company Buy Ratings Hold Ratings Sell Ratings REVSColumbia Research Enhanced Value ETF0 0 0 FNDXSchwab Fundamental US Large Company ETF0 0 0 -
Is REVS or FNDX More Risky?
Columbia Research Enhanced Value ETF has a beta of 0.821, which suggesting that the stock is 17.88% less volatile than S&P 500. In comparison Schwab Fundamental US Large Company ETF has a beta of 0.895, suggesting its less volatile than the S&P 500 by 10.486%.
-
Which is a Better Dividend Stock REVS or FNDX?
Columbia Research Enhanced Value ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.04%. Schwab Fundamental US Large Company ETF offers a yield of 1.58% to investors and pays a quarterly dividend of $0.12 per share. Columbia Research Enhanced Value ETF pays -- of its earnings as a dividend. Schwab Fundamental US Large Company ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios REVS or FNDX?
Columbia Research Enhanced Value ETF quarterly revenues are --, which are smaller than Schwab Fundamental US Large Company ETF quarterly revenues of --. Columbia Research Enhanced Value ETF's net income of -- is lower than Schwab Fundamental US Large Company ETF's net income of --. Notably, Columbia Research Enhanced Value ETF's price-to-earnings ratio is -- while Schwab Fundamental US Large Company ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Columbia Research Enhanced Value ETF is -- versus -- for Schwab Fundamental US Large Company ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income REVSColumbia Research Enhanced Value ETF-- -- -- -- FNDXSchwab Fundamental US Large Company ETF-- -- -- --
-
Which has Higher Returns REVS or FVAL?
Fidelity Value Factor ETF has a net margin of -- compared to Columbia Research Enhanced Value ETF's net margin of --. Columbia Research Enhanced Value ETF's return on equity of -- beat Fidelity Value Factor ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital REVSColumbia Research Enhanced Value ETF-- -- -- FVALFidelity Value Factor ETF-- -- -- -
What do Analysts Say About REVS or FVAL?
Columbia Research Enhanced Value ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity Value Factor ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Columbia Research Enhanced Value ETF has higher upside potential than Fidelity Value Factor ETF, analysts believe Columbia Research Enhanced Value ETF is more attractive than Fidelity Value Factor ETF.
Company Buy Ratings Hold Ratings Sell Ratings REVSColumbia Research Enhanced Value ETF0 0 0 FVALFidelity Value Factor ETF0 0 0 -
Is REVS or FVAL More Risky?
Columbia Research Enhanced Value ETF has a beta of 0.821, which suggesting that the stock is 17.88% less volatile than S&P 500. In comparison Fidelity Value Factor ETF has a beta of 0.956, suggesting its less volatile than the S&P 500 by 4.439%.
-
Which is a Better Dividend Stock REVS or FVAL?
Columbia Research Enhanced Value ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.04%. Fidelity Value Factor ETF offers a yield of 1.59% to investors and pays a quarterly dividend of $0.38 per share. Columbia Research Enhanced Value ETF pays -- of its earnings as a dividend. Fidelity Value Factor ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios REVS or FVAL?
Columbia Research Enhanced Value ETF quarterly revenues are --, which are smaller than Fidelity Value Factor ETF quarterly revenues of --. Columbia Research Enhanced Value ETF's net income of -- is lower than Fidelity Value Factor ETF's net income of --. Notably, Columbia Research Enhanced Value ETF's price-to-earnings ratio is -- while Fidelity Value Factor ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Columbia Research Enhanced Value ETF is -- versus -- for Fidelity Value Factor ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income REVSColumbia Research Enhanced Value ETF-- -- -- -- FVALFidelity Value Factor ETF-- -- -- --
-
Which has Higher Returns REVS or QDEF?
FlexShares Quality Dividend Defensive Index Fund has a net margin of -- compared to Columbia Research Enhanced Value ETF's net margin of --. Columbia Research Enhanced Value ETF's return on equity of -- beat FlexShares Quality Dividend Defensive Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital REVSColumbia Research Enhanced Value ETF-- -- -- QDEFFlexShares Quality Dividend Defensive Index Fund-- -- -- -
What do Analysts Say About REVS or QDEF?
Columbia Research Enhanced Value ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand FlexShares Quality Dividend Defensive Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Columbia Research Enhanced Value ETF has higher upside potential than FlexShares Quality Dividend Defensive Index Fund, analysts believe Columbia Research Enhanced Value ETF is more attractive than FlexShares Quality Dividend Defensive Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings REVSColumbia Research Enhanced Value ETF0 0 0 QDEFFlexShares Quality Dividend Defensive Index Fund0 0 0 -
Is REVS or QDEF More Risky?
Columbia Research Enhanced Value ETF has a beta of 0.821, which suggesting that the stock is 17.88% less volatile than S&P 500. In comparison FlexShares Quality Dividend Defensive Index Fund has a beta of 0.846, suggesting its less volatile than the S&P 500 by 15.371%.
-
Which is a Better Dividend Stock REVS or QDEF?
Columbia Research Enhanced Value ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.04%. FlexShares Quality Dividend Defensive Index Fund offers a yield of 1.71% to investors and pays a quarterly dividend of $0.54 per share. Columbia Research Enhanced Value ETF pays -- of its earnings as a dividend. FlexShares Quality Dividend Defensive Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios REVS or QDEF?
Columbia Research Enhanced Value ETF quarterly revenues are --, which are smaller than FlexShares Quality Dividend Defensive Index Fund quarterly revenues of --. Columbia Research Enhanced Value ETF's net income of -- is lower than FlexShares Quality Dividend Defensive Index Fund's net income of --. Notably, Columbia Research Enhanced Value ETF's price-to-earnings ratio is -- while FlexShares Quality Dividend Defensive Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Columbia Research Enhanced Value ETF is -- versus -- for FlexShares Quality Dividend Defensive Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income REVSColumbia Research Enhanced Value ETF-- -- -- -- QDEFFlexShares Quality Dividend Defensive Index Fund-- -- -- --
-
Which has Higher Returns REVS or ULVM?
VictoryShares US Value Momentum ETF has a net margin of -- compared to Columbia Research Enhanced Value ETF's net margin of --. Columbia Research Enhanced Value ETF's return on equity of -- beat VictoryShares US Value Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital REVSColumbia Research Enhanced Value ETF-- -- -- ULVMVictoryShares US Value Momentum ETF-- -- -- -
What do Analysts Say About REVS or ULVM?
Columbia Research Enhanced Value ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VictoryShares US Value Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Columbia Research Enhanced Value ETF has higher upside potential than VictoryShares US Value Momentum ETF, analysts believe Columbia Research Enhanced Value ETF is more attractive than VictoryShares US Value Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings REVSColumbia Research Enhanced Value ETF0 0 0 ULVMVictoryShares US Value Momentum ETF0 0 0 -
Is REVS or ULVM More Risky?
Columbia Research Enhanced Value ETF has a beta of 0.821, which suggesting that the stock is 17.88% less volatile than S&P 500. In comparison VictoryShares US Value Momentum ETF has a beta of 0.906, suggesting its less volatile than the S&P 500 by 9.36%.
-
Which is a Better Dividend Stock REVS or ULVM?
Columbia Research Enhanced Value ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.04%. VictoryShares US Value Momentum ETF offers a yield of 1.7% to investors and pays a quarterly dividend of $0.02 per share. Columbia Research Enhanced Value ETF pays -- of its earnings as a dividend. VictoryShares US Value Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios REVS or ULVM?
Columbia Research Enhanced Value ETF quarterly revenues are --, which are smaller than VictoryShares US Value Momentum ETF quarterly revenues of --. Columbia Research Enhanced Value ETF's net income of -- is lower than VictoryShares US Value Momentum ETF's net income of --. Notably, Columbia Research Enhanced Value ETF's price-to-earnings ratio is -- while VictoryShares US Value Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Columbia Research Enhanced Value ETF is -- versus -- for VictoryShares US Value Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income REVSColumbia Research Enhanced Value ETF-- -- -- -- ULVMVictoryShares US Value Momentum ETF-- -- -- --
-
Which has Higher Returns REVS or VALQ?
American Century US Quality Value ETF has a net margin of -- compared to Columbia Research Enhanced Value ETF's net margin of --. Columbia Research Enhanced Value ETF's return on equity of -- beat American Century US Quality Value ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital REVSColumbia Research Enhanced Value ETF-- -- -- VALQAmerican Century US Quality Value ETF-- -- -- -
What do Analysts Say About REVS or VALQ?
Columbia Research Enhanced Value ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand American Century US Quality Value ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Columbia Research Enhanced Value ETF has higher upside potential than American Century US Quality Value ETF, analysts believe Columbia Research Enhanced Value ETF is more attractive than American Century US Quality Value ETF.
Company Buy Ratings Hold Ratings Sell Ratings REVSColumbia Research Enhanced Value ETF0 0 0 VALQAmerican Century US Quality Value ETF0 0 0 -
Is REVS or VALQ More Risky?
Columbia Research Enhanced Value ETF has a beta of 0.821, which suggesting that the stock is 17.88% less volatile than S&P 500. In comparison American Century US Quality Value ETF has a beta of 0.863, suggesting its less volatile than the S&P 500 by 13.658%.
-
Which is a Better Dividend Stock REVS or VALQ?
Columbia Research Enhanced Value ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.04%. American Century US Quality Value ETF offers a yield of 1.82% to investors and pays a quarterly dividend of $0.32 per share. Columbia Research Enhanced Value ETF pays -- of its earnings as a dividend. American Century US Quality Value ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios REVS or VALQ?
Columbia Research Enhanced Value ETF quarterly revenues are --, which are smaller than American Century US Quality Value ETF quarterly revenues of --. Columbia Research Enhanced Value ETF's net income of -- is lower than American Century US Quality Value ETF's net income of --. Notably, Columbia Research Enhanced Value ETF's price-to-earnings ratio is -- while American Century US Quality Value ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Columbia Research Enhanced Value ETF is -- versus -- for American Century US Quality Value ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income REVSColumbia Research Enhanced Value ETF-- -- -- -- VALQAmerican Century US Quality Value ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
